Suchergebnisse - "Londoño, Maria Carlota"

PubPharm (147)

1

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors : Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

enthalten in: Gastroenterologia y hepatologia | 2024

von Riveiro-Barciela, M. | Carballal, S. | Díaz-González, �. | +12

2

Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Ampuero, J. | Lucena, A. | Berenguer, M. | +21

3

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization : A nationwide study

enthalten in: Annals of hepatology | 2024

von Barreira-Díaz, A. | Riveiro-Barciela, M. | Fernández-Bonilla, E. | +16

4

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors : Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

enthalten in: Revista espanola de enfermedades digestivas | 2024

von Riveiro-Barciela, M. | Carballal, S. | Díaz-González, �. | +12

5

Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Pocurull, A. | Moreta, M. | Heitman, D. | +11

6

Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients

enthalten in: Journal of hepatology | 2024

von Murray, S. | Pose, E. | Wittner, M. | +37

7

Time since liver transplant and immunosuppression withdrawal outcomes : Systematic review and individual patient data meta-analysis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Appenzeller-Herzog, C. | Rosat, A. | Mathes, T. | +11

8

Corrigendum : PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

ErratumFor: Front Immunol. 2024 Jan 10;14:1326078. - PMID 38268921

9

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 10 January 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

10

Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 24 January 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]